05.10.18
Klöckner Pentaplast's Pharmaceutical & Medical Device Films Division (kp Pharma) is making a €5 million investment in their Cotia, Brazil facility. kp will expand capacity at its Brazilian location to enable new products to be manufactured in the region.
"We are seeing substantial growth in our high barrier product segments in South America in response to the increased temperature, moisture and oxygen sensitivity of new drugs," said Tracey Peacock, president, pharmaceutical and medical device films, kp Pharma. "We are excited to support this key mega trend by adding significant capacity and technical capability to support new products into our Cotia facility."
This latest investment comes about two years after the addition of the fourth slitting line in Cotia, which increased the current site's slitting capacity by approximately 4,000 tons per year.
The new capability is expected to be operational July 2019.
"We are seeing substantial growth in our high barrier product segments in South America in response to the increased temperature, moisture and oxygen sensitivity of new drugs," said Tracey Peacock, president, pharmaceutical and medical device films, kp Pharma. "We are excited to support this key mega trend by adding significant capacity and technical capability to support new products into our Cotia facility."
This latest investment comes about two years after the addition of the fourth slitting line in Cotia, which increased the current site's slitting capacity by approximately 4,000 tons per year.
The new capability is expected to be operational July 2019.